CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

05 10 US PRE OPEN

Article By: ,  Financial Analyst

U.S Futures rising - Watch BMY, MYOK, REGN, IBM, T

The S&P 500 Futures are rebounding after they ended in the red on Friday. On Sunday, Trump's medical team revealed that he could be discharged from hospital on Monday the soonest.

Later today, the Institute for Supply Management will post September Services PMI (56.2 expected). Research firm Markit will unveil the final readings of September Services PMI is expected at 54.6.

European indices are on the upside. Research firm Markit has published final readings of September Services PMI for the eurozone at 48.0 (vs 47.6 expected), for Germany at 50.6 (vs 49.1 expected), for France at 47.5 (vs 47.5 expected) and for the U.K. at 56.1 (vs 55.1 expected). The eurozone's August retail sales rose +4.4% on month (vs +2.5% expected).

Asian indices ended in the green except the Chinese CSI which remains closed for holidays until Thursday. Australia's NAB Business Confidence Index improved to -4 in September from -8 in August.

WTI Crude Oil futures are rebounding. Saudi Arabia's oil production totaled 8.974 million b/d in September, compared with 8.988 million b/d in August, reported Bloomberg citing an industry official.

Gold and the U.S dollar are steady as investors eyes Trump's health news.

Gold fell 0.98 dollar (-0.05%) to 1898.86 dollars.

The dollar index declined 0.23pt to 93.613.


U.S. Equity Snapshot


Bristol-Myers Squibb (BMY), the biopharma company, and MyoKardia (MYOK) "announced a definitive merger agreement under which Bristol Myers Squibb will acquire MyoKardia for 13.1 billion dollars, or 225 dollars per share in cash. The transaction was unanimously approved by both the Bristol Myers Squibb and MyoKardia Boards of Directors and is anticipated to close during the fourth quarter of 2020."


Source: TradingView, GAIN Capital

Regeneron Pharmaceuticals (REGN), the pharma, is soaring before hours as shares were upgraded to "overweight" from "neutral" at Cantor. 

IBM (IBM), an IT company, announced that Bank of Thailand (BOT), the central bank, has successfully launched the world's first blockchain-based platform for government savings bonds issuing a total of 1.6 billion dollars within two weeks.

AT&T (T), one of the largest wireless communication carriers in the U.S., was downgraded to "underweight" from "sector weight" at Keybanc.

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. CFD and Forex Trading are leveraged products and your capital is at risk. They may not be suitable for everyone. Please ensure you fully understand the risks involved by reading our full risk warning.

City Index is a trading name of StoneX Financial Ltd. Head and Registered Office: 1st Floor, Moor House, 120 London Wall, London, EC2Y 5ET. StoneX Financial Ltd is a company registered in England and Wales, number: 05616586. Authorised and regulated by the Financial Conduct Authority. FCA Register Number: 446717.

City Index is a trademark of StoneX Financial Ltd.

The information on this website is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement.

© City Index 2024